Does MERCAPTOPURINE Cause Interstitial lung disease? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Interstitial lung disease have been filed in association with MERCAPTOPURINE (Mercaptopurine). This represents 0.5% of all adverse event reports for MERCAPTOPURINE.
58
Reports of Interstitial lung disease with MERCAPTOPURINE
0.5%
of all MERCAPTOPURINE reports
15
Deaths
46
Hospitalizations
How Dangerous Is Interstitial lung disease From MERCAPTOPURINE?
Of the 58 reports, 15 (25.9%) resulted in death, 46 (79.3%) required hospitalization, and 13 (22.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MERCAPTOPURINE. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does MERCAPTOPURINE Cause?
Febrile neutropenia (1,853)
Off label use (893)
Pyrexia (855)
Drug ineffective (721)
Vomiting (488)
Neutropenia (485)
Nausea (418)
Pneumonia (394)
Pancytopenia (392)
Sepsis (389)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MERCAPTOPURINE Alternatives Have Lower Interstitial lung disease Risk?
MERCAPTOPURINE vs MEROPENEM
MERCAPTOPURINE vs MEROPENEM ANHYDROUS
MERCAPTOPURINE vs MESALAMINE
MERCAPTOPURINE vs MESNA
MERCAPTOPURINE vs METAMIZOLE